Cargando…
Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1
Tyrosinemia type 1 (TT1) is a rare metabolic disease caused by a defect in tyrosine catabolism. TT1 is clinically characterized by acute liver failure, development of hepatocellular carcinoma, renal and neurological problems, and consequently an extremely poor outcome. This review showed that the in...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885500/ https://www.ncbi.nlm.nih.gov/pubmed/31667718 http://dx.doi.org/10.1007/s40272-019-00364-4 |